1. Antivirals reduced hospitalization, intensive care unit admission, and mortality in non-severe influenza.
2. Mortality risk was significantly lower with treatment (risk ratio 0.60).
3. Benefits were consistent across sensitivity and subgroup analyses.
4. Effects extended to younger, low-risk patients.
5. Observational design limits causal interpretation.

Source: BMC Medicine